NCT03200951

Brief Summary

Ultrasonography of optic nerve sheath diameter shows a good level of diagnostic accuracy for detecting intracranial hypertension. The aim of this study is to evaluate the effect of epidural block on intracranial pressure in pediatric patients with cerebral palsy undergoing osteotomy of lower extremity. Forty patients, aged 4 years to 13 years, receiving epidural block before osteotomy will be divided into bolus group (n=20) and infusion group (n=20). Randomly selected patients of the bolus group are given 0.3 ml/kg bolus of 0.15% ripivacaine for epidural block. In contrast, patients in the infusion group are given 0.3 ml/kg/hr 0.15% ripivacaine for epidural block. The primary endpoint is the difference in the optic nerve sheath diameter after epidural block measured by optic nerve ultrasonography between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 27, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

August 22, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

October 29, 2018

Status Verified

October 1, 2018

Enrollment Period

9 months

First QC Date

June 22, 2017

Last Update Submit

October 25, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • The difference in the optic nerve sheath diameter(ONSD) between groups

    The optic nerve sheath diameter measured by optic nerve ultrasonography.

    5 minutes before epidural block

  • The difference in the optic nerve sheath diameter(ONSD) between groups

    The optic nerve sheath diameter measured by optic nerve ultrasonography.

    1 second after epidural block

  • The difference in the optic nerve sheath diameter(ONSD) between groups

    The optic nerve sheath diameter measured by optic nerve ultrasonography.

    10 minutes after epidural block

  • The difference in the optic nerve sheath diameter(ONSD) between groups

    The optic nerve sheath diameter measured by optic nerve ultrasonography.

    70 minutes after epidural block

Secondary Outcomes (4)

  • The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups

    5 minutes before epidural block

  • The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups

    1 second after epidural block

  • The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups

    10 minutes after epidural block

  • The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groups

    70 minutes after epidural block

Study Arms (2)

Bolus group

EXPERIMENTAL
Drug: Bolus group for epidural block

Infusion group

ACTIVE COMPARATOR
Drug: Infusion group for epidural block

Interventions

Randomly selected patients of the bolus group are given 0.3 ml/kg bolus of 0.15% ripivacaine for epidural block.

Also known as: ripivacaine
Bolus group

Randomly selected patients of the infusion group are given 0.3 ml/kg/hr 0.15% ripivacaine for epidural block.

Also known as: ripivacaine
Infusion group

Eligibility Criteria

Age4 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients with cerebral palsy from 4 to 13 years of age undergoing osteotomy
  • Body weight ≤ 40 kg

You may not qualify if:

  • Patients with contraindications to epidural analgesia (local infection, clotting disorders, anatomical abnormalities, sepsis, etc.)
  • Patients with symptoms or signs associated with a history of elevated intracranial pressure or elevated intracranial pressure
  • Patients with ophthalmic disease or surgery
  • The estimated operation time is less than 70 minutes.
  • All parents of the subject are foreigners or illiterate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine

Seoul, 03722, South Korea

Location

Related Publications (2)

  • Lin Y, Li Q, Liu J, Yang R, Liu J. Comparison of continuous epidural infusion and programmed intermittent epidural bolus in labor analgesia. Ther Clin Risk Manag. 2016 Jul 14;12:1107-12. doi: 10.2147/TCRM.S106021. eCollection 2016.

    PMID: 27471390BACKGROUND
  • Padayachy LC, Padayachy V, Galal U, Pollock T, Fieggen AG. The relationship between transorbital ultrasound measurement of the optic nerve sheath diameter (ONSD) and invasively measured ICP in children. : Part II: age-related ONSD cut-off values and patency of the anterior fontanelle. Childs Nerv Syst. 2016 Oct;32(10):1779-85. doi: 10.1007/s00381-016-3068-4. Epub 2016 Sep 20.

    PMID: 27659820BACKGROUND

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Anesthesia, Epidural

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants and investigator are blinded to group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomly selected patients of the bolus group are given 0.3 ml/kg bolus of 0.15% ripivacaine for epidudral block. In contrast, patients in the infusion group are given 0.3 ml/kg/hr 0.15% ripivacaine for epidural block.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2017

First Posted

June 27, 2017

Study Start

August 22, 2017

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

October 29, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations